Concerns are frequently raised in the pharmaceutical industry over the danger that when clinical trials are outsourced to contact research organisations (CROs), ethical protections might take a backseat to quicker and cheaper new product development.
Concerns are frequently raised in the pharmaceutical industry over the danger that when clinical trials are outsourced to contact research organisatio ...
Satisfied Users & 
Approved Press Releases
